Literature DB >> 24583422

Low-dose aspirin and comorbidities are significantly related to bleeding peptic ulcers in elderly patients compared with nonelderly patients in Japan.

Toru Higuchi1, Ryuichi Iwakiri, Megumi Hara, Ryo Shimoda, Yasuhisa Sakata, Atsushi Nakayama, Kenta Nio, Shunsuke Yamaguchi, Daisuke Yamaguchi, Akira Watanabe, Takashi Akutagawa, Hiroyuki Sakata, Kazuma Fujimoto.   

Abstract

OBJECTIVE: The present study was conducted using data accumulated from our earlier study of bleeding peptic ulcers, focusing on elderly patients.
METHODS: A total of 461 patients with bleeding peptic ulcers underwent emergency endoscopy at Saga Medical School Hospital between 1999 and 2011. Risk factors for bleeding peptic ulcers were compared between two groups: an elderly group (≥65 years old) and a nonelderly group (<65 years old). The relationship between drug use and age was examined using multiple logistic regression models. In the elderly group, the factors were compared between Period I (1999-2005) and Period II (2006-2011).
RESULTS: The proportion of men and the incidence of Helicobacter pylori infection were lower in the elderly group than in the nonelderly group. The use of low-dose aspirin, antithrombotic drugs and corticosteroids, but not nonsteroidal anti-inflammatory drugs, was higher in the elderly group. A multiple logistic regression analysis of prescribed medications indicated that low-dose aspirin was more frequently used in the elderly group. The rate of comorbidities was higher and the hemoglobin levels were lower in the elderly group. The rates of rebleeding within one week and death within one month did not differ in the elderly group. Compared with that observed in Period I, the incidence of Helicobacter pylori infection was decreased and the rate of comorbidities was increased in Period II.
CONCLUSION: This study indicates that factors related to bleeding peptic ulcers in elderly patients have shifted from Helicobacter pylori infection to comorbidities associated with low-dose aspirin, suggesting a close relationship between low-dose aspirin therapy and comorbidities in elderly patients with peptic ulcers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583422     DOI: 10.2169/internalmedicine.53.0603

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Renal Dysfunction is an Independent Risk Factor for Rebleeding After Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding.

Authors:  Hideharu Ogiyama; Shusaku Tsutsui; Yoko Murayama; Kensuke Matsushima; Shingo Maeda; Shin Satake; Kayo Seto; Masashi Horiki; Tamana Sanomura; Kazuho Imanaka; Hiroyasu Iishi
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

2.  Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan.

Authors:  Susumu Fujii; Megumi Hara; Sayuri Nonaka; Shinichiro Ishikawa; Yosuke Aoki; Keizo Anzai; Shigeki Morita; Kazuma Fujimoto; Masaaki Mawatari
Journal:  J Clin Biochem Nutr       Date:  2016-07-01       Impact factor: 3.114

3.  Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers.

Authors:  Anca Negovan; Mihaela Iancu; Valeriu Moldovan; Septimiu Voidazan; Simona Bataga; Monica Pantea; Kinga Sarkany; Cristina Tatar; Simona Mocan; Claudia Banescu
Journal:  Gastroenterol Res Pract       Date:  2016-08-08       Impact factor: 2.260

4.  Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study.

Authors:  Daisuke Yamaguchi; Naoyuki Tominaga; Koichi Miyahara; Nanae Tsuruoka; Yasuhisa Sakata; Yuki Takeuchi; Takuya Matsunaga; Hidenori Hidaka; Takashi Akutagawa; Takahiro Noda; Shinichi Ogata; Seiji Tsunada; Motohiro Esaki
Journal:  Can J Gastroenterol Hepatol       Date:  2021-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.